Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Pharmaceutical Sovereignty Put to the Test by Ebola

Pharmaceutical sovereignty is back in focus as Ebola spreads in the DRC. See how pooled procurement and shared regulation could secure supplies.
Pharmaceutical Sovereignty Put to the Test by Ebola
AI Image | OlgaKris | Adobe Stock/2034455596

The Ebola outbreak in the Democratic Republic of the Congo (DRC) has renewed the case for pharmaceutical sovereignty in Africa. The country reported 10,668 confirmed cases and 5,198 deaths up until 3 November, according to the European Centre for Disease Prevention and Control. The centre says the DRC is still reconciling its case and death counts.

Frontline teams need reliable supplies of gloves, masks, protective gowns and disinfectants to limit transmission in health facilities. Rapid diagnostics are equally important. They help teams identify cases, isolate patients and trace contacts before the virus spreads further. When health workers fall ill, facilities also lose staff needed to maintain routine care.

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

05.11.2026

Rare disease funding is under scrutiny after the KeyHealth ruling. See how schemes could share the cost of treatments such as Ultomiris.

05.11.2026

Essential medicine shortages threaten 165 public sector products in South Africa. See what is disrupting supply and how the department is responding.

05.11.2026

Retail pharmacy competition is squeezing Dis-Chem’s earnings as Clicks expands loyalty discounts. Shoprite’s Sixty60 is also in focus.